use in Medical Technology

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

ROCKVILLE, Md., July 6 /PRNewswire-USNewswire/ -- A procedure that sends targeted energy into the heart through a catheter can be used to treat a common type of irregular heartbeat, but little is known about the treatment's long-term benefits and the best methods and circumstances for applying it,...

McCaughey Urges Use of First NYS Hospital Infection Report

NEW YORK, June 30 /PRNewswire-USNewswire/ -- Betsy McCaughey of the Committee to Reduce Infection Deaths (RID) urges families to make use of hospital infection rates made available by the NYS Department of Health today. "Now patients can learn which hospitals in their area have the lowest infecti...

Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System

New Capabilities Will Further Extend GeneXpert System Technology Advantages SUNNYVALE, Calif., June 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today announced that it has received a notice of grant award from the National Institute of Allergy and Infectious Diseases to develop new...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

Pre-heparinization Limits Clot Retention and Decreases Residual Clot Volume SAN FRANCISCO, June 8 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administ...

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials

ABBOTT PARK, Ill., May 7 /PRNewswire-FirstCall/ -- The Abbott RealTi m e HIV-1 Assay and Abbott m 2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH). This recommendation was ma...

New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health

LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Several new studies presented at the American Urological Association's (AUA) 104th Annual Scientific Meeting suggest that the use of statins--commonly prescribed to lower cholesterol--may benefit men with prostate cancer, erectile dysfunction or ...

Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line

Only 39 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources WALTHAM, Mass., April 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceut...

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that it has entered into an asset purchase agreement with Bio-GAL Ltd, a private company, for the rights to a use patent on Recombinant Erythropoietin ("rHuEPO") for the...

Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease

Surveyed Neurologists and PCPs Vary in Their Prescribing Patterns of Levodopa/Carbidopa and Dopamine Agonists, According to a New Report from Decision Resources WALTHAM, Mass., March 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharm...

Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone

SEATTLE, Feb. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (NASDAQ and MTA: CTIC) today announced that they have executed a definitive collaborative agreement with IDIS to manage its investigational drug pixantrone on a named patient basis in Europe. Pixantrone will be supplied by IDIS to...

Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults

PHILADELPHIA, Feb. 2 /PRNewswire-USNewswire/ -- Adolescents and young adults who are heavy users of marijuana are more likely than non-users to have disrupted brain development, according to a new study. Pediatric researchers found abnormalities in areas of the brain that interconnect brain region...

British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection

University of Nottingham Scientists Leading Major Study into Lethal 'Super' Strains of C.difficile CHICAGO, Jan. 28 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham are leading a major European study to unravel the ...

Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults

ANN ARBOR, Mich., Jan. 16 /PRNewswire/ -- Use of prescription sleep aids nearly tripled among 18- to 24-year-olds between 1998 and 2006, according to a study released today by the Healthcare business of Thomson Reuters. During the study period, the average length of time sleep aids were...

Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients

WASHINGTON, Dec. 30 /PRNewswire-USNewswire/ -- The Coalition for 21st Century Medicine strongly opposes the citizen petition filed by Genentech, Inc. on December 5, 2008, seeking to restrict the ability of laboratories to offer diagnostic tests to physicians and patients. The request threatens in...

PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications

PALO ALTO, Calif., Dec. 17 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its PEAK...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- The largest study ever to examine the preventive use of blood-thinning medication to help prevent deadly blood clots in patients with cancer undergoing chemotherapy will be presented in a press conference on Sunday, December 7, at 9:30 a.m., during ...

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting

PHILADELPHIA, Nov. 7 /PRNewswire/ -- Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT(R) (Epoetin alfa) in treating anemia in subjects with Stages 3 - 4 chronic kidney disease (CKD) were presented today at the American Society of Nephrolo...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

A study from St. Jude scientists shows how microbes can block nitric oxide production - a chemical key to the immune system - and offers hints for fighting bacteria MEMPHIS, Tenn., Nov. 3 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital scientists have discovered a mechanism ...

Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD

- Study showed no consistent differences in bone mineral density at the lumbar spine and total hip between Advair Diskus 250/50 (fluticasone propionate and salmeterol inhalation powder) and salmeterol - Study provides support for long term use of Advair(R) in patients with COPD PHILADELPHI...

Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System

Study Will Investigate Using Cooling Device to Treat Heart Attack Victims WALDWICK, N.J., Oct. 20 /PRNewswire/ -- Life Recovery Systems has received a competitively awarded $700,000 grant from the National Institutes of Health (NIH) to conduct a clinical study to investigate the feasibility ...

Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)

Additional Data Presentation Shows Encouraging 12-Month Outcomes from Single- Center Study Involving Patients with Predominantly Complex Lesions WASHINGTON, Oct. 14 /PRNewswire/ -- OrbusNeich today announced that an interim analysis of 12-month follow-up data from the global e-HEALING regist...

Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy

Quark siRNAs Examined Alone and in Combination with Chemotherapy FREMONT, Calif. Oct. 12 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that the journal Cance...

Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees

BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- "A return to the use of chimpanzees in AIDS research and vaccine development is without scientific justification," according to a paper released today in the journal Alternatives to Laboratory Animals (ATLA). "An Assessment of the Role of Chimpanzees i...

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)

IRVINE, Calif., Sept. 26 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that it met with representatives of the Committee for Medicinal Products for Human Use (CHMP) and Secretariat of the European Medicines Agency (EMEA) on September 25th, following the CHMP's Sep...

New Computer-Based Tools Will Help Make Best Use of Genetic Breast Cancer Tests

ROCKVILLE, Md., Sept. 22 /PRNewswire-USNewswire/ -- A new federal project, funded by the Agency for Healthcare Research and Quality, will lead efforts to develop, implement and evaluate four computer-based decision-support tools that will help clinicians and patients better use genetic tests to...

Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients

- Results Demonstrating 95 Percent or Greater Concordance Compared to FISH and IHC Presented at 2008 ASCO Breast - - Company to Include Reporting for HER2 Gene Expression in All Oncotype DX Reports by End of 2008 - REDWOOD CITY, Calif., Sept. 6 /PRNewswire...

Prescription Sleeping Pill Use Tied to Cancer

SAN DIEGO, Aug. 18 /PRNewswire/ -- The next time you consider popping a pill when you have trouble nodding off, it might be worth counting sheep instead. A senior psychiatrist at the Scripps Clinic Sleep Center in San Diego, Calif. has found evidence that taking sleeping pills regularly can in...

Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases

EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that it had filed a patent application for the use of compounds the company is developing for treatment of brain tumors as potential treatments for neurodegenera...

Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent

SAN DIEGO, Aug. 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced the publication of three clinical trials on the use of OraVerse (phentolamine mesylate) injection as a local dental anesthetic reversal agent in the August 2008 issue of the J...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

WOBURN, Mass., July 15 /PRNewswire/ -- AdvanDx today announced that a new study shows use of AdvanDx's PNA FISH(TM) test was associated with an 82% reduction in mortality rates from S. aureus bloodstream infections in the intensive care unit (ICU), a 53% reduction in overall mortality from sta...

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)

- Company continues to anticipate CHMP opinion in the third quarter; L-MTP-PE on track for final European Commission decision in the fourth quarter IRVINE, Calif., July 1 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that the CH...

Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells

Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the publication of data demonstrating that human immune system cells (C...

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)

sBLA Submission Based on Data from Placebo-Controlled Phase III Trial; Largest Enrollment of CTCL Patients in a Randomized Study WOODCLIFF LAKE, N.J., June 26 /PRNewswire/ -- Eisai Corporation of North America announced today that the U.S. Food and Drug Administration (FDA) has accepted...

Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema

SAN DIEGO, June 12 /PRNewswire/ -- Recent guidelines published by the Clinical Resource Efficiency Support Team (CREST) provide further support for the use of bioimpedance technology for the early assessment of lymphedema. The published guidelines for Northern Ireland titled "Guidelines for ...

AlphaVax Continues to Expand the Use of Its Vaccine Platform

RESEARCH TRIANGLE PARK, N.C., June 6 /PRNewswire/ -- AlphaVax, Inc. recently received notification from the National Institute of Allergies and Infectious Diseases (NIAID), one of the granting institutes of the National Institutes of Health (NIH), that it has been awarded a second grant to con...

Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients

- Phase II Data Indicate Overall and Disease-Free Survival - WAYNE, N.J., June 5 /PRNewswire/ -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine(R) (sargramostim) achieved disease-free and/or overall survival. Th...

Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis

-- Phase 1 RDEA119 data expected in second half of 2008 -- -- Presentation at the Seventh Annual JMP Securities Research Conference on May 21st canceled; webcast of corporate update scheduled during Ardea's Annual Stockholder Meeting on May 22nd at 9:30 a.m. PT -- SAN DIEGO, May...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

-- Clinical trial data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution presented at International ATS Conference -- NAPA, Calif., May 20 /PRNewswire/ -- Data presented today at the International Conference of the American Thoracic Society (ATS) demonstrate that concomitant ...

First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System

Excellent results obtained with a newly cleared device to identify the lipid core (fatty) coronary plaques of interest that are associated with complications of coronary stenting BURLINGTON, Mass., May 15 /PRNewswire/ -- InfraReDx, Inc. today announced that physicians at B...

Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents

Randomized TRIAS HR Pilot Study Compares Genous, Boston Scientific's Taxus(R) Other Presentations Focus on Real-World Use of Genous, Stent's Performance in Patients with AMI, Those Who Could Not Tolerate Dual-Antiplatelet Therapy ...